Neurogene Inc

Stock Chart, Company Information, and Scan Results

$20.99(as of Oct 2, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Neurogene Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$20.99
Ticker SymbolNGNE
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees107
CountyUSA
Market Cap$256.5M
EBIDTA-92.6M
10-Day Moving Average17.75
P/E Ratio-5.23
20-Day Moving Average18.26
Forward P/E Ratio0.00
50-Day Moving Average19.66
Earnings per Share-4.47
200-Day Moving Average18.08
Profit Margin-Infinity%
RSI63.24
Shares Outstanding14.3M
ATR1.30
52-Week High74.49
Volume507,583
52-Week Low6.88
Most Recent Support Level17.18
Book Value273.3M
Most Recent Resistance Level18.15
P/B Ratio1.62
Upper Keltner21.17
P/S Ratio-477.56
Lower Keltner15.34
Debt-to-Equity Ratio21.17
Next Earnings DateUnknown
Cash Surplus43.4M
Next Ex-Dividend DateUnknown

Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.

Neurogene Inc In Our Stock Scanner

As of Oct 03, 2025
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.